Press "Enter" to skip to content

New patent for Astrazeneca Ab drug BREZTRI AEROSPHERE

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug BREZTRI AEROSPHERE

Annual Drug Patent Expirations for BREZTRI+AEROSPHERE
Annual Drug Patent Expirations for BREZTRI+AEROSPHERE

Breztri Aerosphere is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.

This drug has one hundred and forty-three patent family members in thirty-one countries.

The generic ingredient in BREZTRI AEROSPHERE is budesonide; formoterol fumarate; glycopyrrolate. One supplier is listed for this compound. Additional details are available on the budesonide; formoterol fumarate; glycopyrrolate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug BREZTRI AEROSPHERE
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions